[
    [
        {
            "time": "",
            "original_text": "长春高新：重组人生长激素注射液获批增加五项新适应症",
            "features": {
                "keywords": [
                    "长春高新",
                    "重组人生长激素",
                    "注射液",
                    "新适应症"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "长春高新：重组人生长激素注射液获批增加五项新适应症",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "长春高新(000661.SZ)：金赛药业重组人生长激素注射液相关剂型增加适应症获批",
            "features": {
                "keywords": [
                    "长春高新",
                    "金赛药业",
                    "重组人生长激素",
                    "注射液",
                    "适应症"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "长春高新(000661.SZ)：金赛药业重组人生长激素注射液相关剂型增加适应症获批",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "午间公告：雄韬股份与中国南山集团围绕氢能源产业链达成战略合作；长春高新重组人生长激素注射液新适应症补充申请获得批准",
            "features": {
                "keywords": [
                    "长春高新",
                    "重组人生长激素",
                    "注射液",
                    "新适应症",
                    "雄韬股份",
                    "中国南山集团",
                    "氢能源产业链",
                    "战略合作"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "新能源"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "午间公告：雄韬股份与中国南山集团围绕氢能源产业链达成战略合作；长春高新重组人生长激素注射液新适应症补充申请获得批准",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "长春高新：生长激素不同适应症用的是同一种",
            "features": {
                "keywords": [
                    "长春高新",
                    "生长激素",
                    "适应症"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "长春高新：生长激素不同适应症用的是同一种",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "长春高新：公司回购的资金总额为人民币6亿元，回购价格不超过人民币400元/股",
            "features": {
                "keywords": [
                    "长春高新",
                    "回购",
                    "资金总额",
                    "回购价格"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "长春高新：公司回购的资金总额为人民币6亿元，回购价格不超过人民币400元/股",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]